Department of Public Policy, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan.
Bioethics Section, Center for Clinical Sciences, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
J Hum Genet. 2023 Sep;68(9):579-585. doi: 10.1038/s10038-023-01163-z. Epub 2023 Jun 8.
Genetic discrimination (GD) has not been discussed in East Asia as extensively as in Europe and North America. Influenced by UNESCO's universal declaration in 1997, the Japanese government took a stringent approach toward GD by releasing the Basic Principles on Human Genome Research in 2000. However, Japanese society has mostly been ignoring the prevention of GD for decades, and the principle of prohibiting GD was never adhered to in any of the Japanese laws. We conducted anonymous surveys among the general adult population in 2017 and 2022 to explore their experiences of GD and attitudes toward laws carrying penalties to prevent GD in Japan. In both years, approximately 3% of the respondents had experienced some unfavorable treatment regarding their genetic information. They showed higher recognition of the benefits of using genetic information and lower recognition of concerns about using genetic information and GD in 2022 than in 2017. However, the awareness regarding the need for legislation with penalties on GD had increased over the five-year period. In 2022, the framework of a bill to promote genomic medicine and prevent GD without any relevant penalties was released by the Bipartisan Diet Members Caucus. Considering that the absence of regulations may be a barrier to obtaining genomic medicine, as the initial step toward making the prohibition of GD more effective, legislation that no form of GD will be tolerated may stimulate education and awareness regarding respect for the human genome and its diversity.
遗传歧视(GD)在东亚的讨论不如在欧洲和北美的广泛。受联合国教科文组织 1997 年宣言的影响,日本政府通过 2000 年发布《人类基因组研究基本准则》,对 GD 采取了严格的态度。然而,几十年来,日本社会大多忽略了 GD 的预防,禁止 GD 的原则从未在任何日本法律中得到遵守。我们在 2017 年和 2022 年对普通成年人群进行了匿名调查,以探讨他们在日本的 GD 经历和对带有防止 GD 处罚的法律的态度。在这两年中,约有 3%的受访者在他们的遗传信息方面经历了一些不利的待遇。与 2017 年相比,他们在 2022 年对使用遗传信息的好处有更高的认识,对使用遗传信息和 GD 的担忧有更低的认识。然而,对制定具有 GD 处罚的立法的必要性的认识在五年期间有所增加。2022 年,两党参议员小组发布了一项促进基因组医学和防止 GD 的法案框架,没有任何相关的处罚。考虑到缺乏监管可能是获得基因组医学的障碍,作为使 GD 禁止更加有效的初始步骤,不允许任何形式的 GD 的立法可能会刺激对人类基因组及其多样性的尊重的教育和认识。